The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Plasma Fractionation Market Through 2030?
The plasma fractionation market has seen substantial expansion in recent years. It is projected to grow from $34.14 billion in 2025 to $37.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.2%. This historical growth can be linked to several factors, including an increase in demand for immunoglobulins, a rise in the occurrence of hematological disorders, continuous technological advancements within plasma fractionation, the broadening of hospital and clinical infrastructure, and enhanced public awareness regarding plasma-derived treatments.
The plasma fractionation market is anticipated to experience substantial growth in the upcoming years. It is set to expand to $55.85 billion in 2030, achieving a compound annual growth rate (CAGR) of 10.4%. This projected growth within the forecast period can be attributed to the increasing embrace of precision medicine, the incorporation of artificial intelligence in plasma manufacturing, the broadening of global biopharmaceutical partnerships, heightened investments in plasma collection centers, and the creation of innovative plasma-derived treatments. Prominent trends for the forecast period include advanced plasma fractionation techniques, the diversification of biopharmaceutical products, improved quality control and regulatory adherence, the expansion of contract manufacturing organizations (CMOs/CDMOs), and efforts to optimize the supply chain for plasma products.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp
What Important Drivers Are Powering The Plasma Fractionation Market Growth?
The increasing number of chronic diseases is anticipated to stimulate the expansion of the plasma fractionation market in the coming period. Chronic diseases are defined as conditions that persist for 1 year or longer and demand continuous medical care, with examples including heart disease, cancer, and diabetes. Treating patients with chronic diseases by providing access to plasma products is effective in reducing morbidity, improving their quality of life, and being cost-effective, factors that will subsequently boost the demand for plasma fractionation. For instance, in March 2025, according to GOV.UK, a UK-based non-profit government organization, general practitioners documented type 2 diabetes prevalence in adults as 7.0% for those aged 17 and over in England in March 2024, a rise from 6.8% in March 2023. Consequently, a growing incidence of chronic diseases across all age groups is expected to propel the plasma fractionation market growth.
How Does Segment Analysis Break Down The Plasma Fractionation Market Structure?
The plasma fractionation market covered in this report is segmented –
1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors
2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology
3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes
Subsegments:
1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)
3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)
4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)
What Trends Are Driving Changes In The Plasma Fractionation Market?
Leading companies in the market are implementing novel technologies, including high-tech facility processes that transform donated human plasma into essential medicines, utilizing advanced methods to enhance efficiency and safety. For example, in March 2023, CSL Behring, a German-based company, inaugurated a new $470 million plasma fractionation facility. This facility incorporates cutting-edge technology to elevate the efficiency and safety of plasma processing, guaranteeing higher quality and more dependable medicines. By expanding the supply of these vital medicines, the facility assists in meeting increasing demand, ensuring a greater number of patients can access life-saving treatments. Its advanced automation and self-cleaning systems contribute to reducing contamination risks and improving overall hygienic conditions, thereby enhancing patient safety.
Which Firms Are Competing In The Plasma Fractionation Market?
Major companies operating in the plasma fractionation market are Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP
Access The Complete Plasma Fractionation Market Report:
https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report
Which Region Commands The Largest Share Of The Plasma Fractionation Market?
North America was the largest region in the plasma fractionation market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Plasma Fractionation Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp
Browse Through More Reports Similar to the Global Plasma Fractionation Market 2026, By The Business Research Company
Plasma Fractionation Market Report 2026
https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report
Plasma Powder Market Report 2026
https://www.thebusinessresearchcompany.com/report/plasma-powder-global-market-report
Blood Plasma Derivatives Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model